183 related articles for article (PubMed ID: 1342474)
1. [Anticardiolipin antibodies in connective tissue diseases].
Cerda C; Neira O; Palma S; Abumohor P; Basualdo J; Alvarado MA; Guzmán L
Rev Med Chil; 1992 Mar; 120(3):239-43. PubMed ID: 1342474
[TBL] [Abstract][Full Text] [Related]
2. The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases.
Merkel PA; Chang Y; Pierangeli SS; Convery K; Harris EN; Polisson RP
Am J Med; 1996 Dec; 101(6):576-83. PubMed ID: 9003103
[TBL] [Abstract][Full Text] [Related]
3. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC
Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702
[TBL] [Abstract][Full Text] [Related]
4. Comparison between the standard anticardiolipin antibody test and a new phospholipid test in patients with connective tissue diseases.
Merkel PA; Chang Y; Pierangeli SS; Harris EN; Polisson RP
J Rheumatol; 1999 Mar; 26(3):591-6. PubMed ID: 10090168
[TBL] [Abstract][Full Text] [Related]
5. Radioimmunoassay profile of antiglobulins in connective tissue diseases: elevated level of IgA antiglobulin in systemic sicca syndrome.
Elkon KB; Caeiro F; Gharavi AE; Patel BM; Ferjencik PP; Hughes GR
Clin Exp Immunol; 1981 Dec; 46(3):547-56. PubMed ID: 6978220
[TBL] [Abstract][Full Text] [Related]
6. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
7. IgG and IgM anticardiolipin antibodies following treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis.
Visvanathan S; Wagner C; Smolen J; St Clair EW; Hegedus R; Baker D; Keenan G
Arthritis Rheum; 2006 Sep; 54(9):2840-4. PubMed ID: 16948115
[TBL] [Abstract][Full Text] [Related]
8. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
[TBL] [Abstract][Full Text] [Related]
9. [Significance of antinuclear antibodies in the diagnosis of connective tissue diseases].
Bambara LM; Biasi D; Caramaschi P; Codella O; Corrocher R; Serpelloni G; De Sandre G
Recenti Prog Med; 1985 Feb; 76(2):102-9. PubMed ID: 3887516
[No Abstract] [Full Text] [Related]
10. [Anticardiolipin antibodies in diffuse connective tissue diseases with IgG, IgM and IgA isotypes].
Hrncír Z; Chýlková V
Vnitr Lek; 1990 Nov; 36(11):1041-9. PubMed ID: 2267732
[TBL] [Abstract][Full Text] [Related]
11. Anti-Ro/SSA and -La/SSB antibodies in patients with connective tissue diseases.
Yamagata H; Akizuki M; Tojo T; Homma M
Scand J Rheumatol Suppl; 1986; 61():98-101. PubMed ID: 3495876
[TBL] [Abstract][Full Text] [Related]
12. Disease distribution of beta 2-glycoprotein I-dependent anticardiolipin antibodies in rheumatic diseases.
Kaburaki J; Kuwana M; Yamamoto M; Kawai S; Matsuura E; Ikeda Y
Lupus; 1995 Feb; 4 Suppl 1():S27-31. PubMed ID: 7757107
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to ribosomal ribonucleoprotein. Prevalence in systemic rheumatic diseases and partial characterization of the antigen.
Cortés JJ; Mendoza F; Reyes PA
J Rheumatol; 1987 Aug; 14(4):727-31. PubMed ID: 3118019
[TBL] [Abstract][Full Text] [Related]
14. IgG, IgA, IgM antibodies to a viral citrullinated peptide in patients affected by rheumatoid arthritis, chronic arthritides and connective tissue disorders.
Anzilotti C; Riente L; Pratesi F; Chimenti D; Delle Sedie A; Bombardieri S; Migliorini P
Rheumatology (Oxford); 2007 Oct; 46(10):1579-82. PubMed ID: 17717033
[TBL] [Abstract][Full Text] [Related]
15. Clinical and serological heterogeneity in patients with anticentromere antibodies.
Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
[TBL] [Abstract][Full Text] [Related]
16. [Difficulties in differential diagnosis of Sjögren's syndrome and systemic lupus erythematosus].
Krawiec P; Batko B; Skura A; Adamek-Guzik T; Cześnikiewicz-Guzik M; Krzanowski M; Rydz-Stryszowska I; Ryszawa N; Guzik TJ
Przegl Lek; 2006; 63(5):278-83. PubMed ID: 17036505
[TBL] [Abstract][Full Text] [Related]
17. [Significance of antinuclear anti-histone antibodies].
Ferec C; Youinou P; Le Goff P; Miossec P; Morin JF; Pennec Y; Morin PP; Le Menn G
Ann Med Interne (Paris); 1984; 135(6):427-30. PubMed ID: 6334466
[TBL] [Abstract][Full Text] [Related]
18. Anti-ribosomal P protein antibodies detected by immunoblotting in patients with connective tissue diseases: their specificity for SLE and association with IgG anticardiolipin antibodies.
Ghirardello A; Doria A; Zampieri S; Gerli R; Rapizzi E; Gambari PF
Ann Rheum Dis; 2000 Dec; 59(12):975-81. PubMed ID: 11087701
[TBL] [Abstract][Full Text] [Related]
19. Relationship of Sjögren's syndrome to other connective tissue and autoimmune disorders.
Theander E; Jacobsson LT
Rheum Dis Clin North Am; 2008 Nov; 34(4):935-47, viii-ix. PubMed ID: 18984413
[TBL] [Abstract][Full Text] [Related]
20. Dermatopathology of connective tissue diseases.
Costner MI; Jacobe H
Adv Dermatol; 2000; 16():323-59; discussion 360. PubMed ID: 11094633
[No Abstract] [Full Text] [Related]
[Next] [New Search]